Literature DB >> 12428715

Parkinson's disease: current and future challenges.

J William Langston1.   

Abstract

In 15 years, we will mark the 200th anniversary of the James Parkinson's original description of the disease that now bears his name (An Essay on the Shaking Palsy, Sherwood, Neely and Jones London, 1817). Perhaps, one of the most exciting but daunting questions we face at this moment is whether or not we can unravel the etiology of the disease by that time. If we are to accomplish such an ambitious goal, we must determine the resources that will be required to make it happen, and identify the areas of scientific focus that should receive the greatest attention. One issue that will have great bearing on the allocation of research resources relates to the relative roles of genes versus environment in disease causation. For reasons that will become clear in this article, this has a remained surprisingly controversial area. Ironically, this controversy has even spilled over to the very definition of Parkinson's disease, and even whether or not it should be considered a disease entity. In this article, the enduring "genes versus environment" debate is reviewed, with a goal of putting it into a broader perspective. Issues surrounding disease definition and terminology are also addressed in detail, because of the need to have clarity of thought and vision if research on the cause is to proceed in an orderly (and hopefully expeditious) manner. Finally, issues relating future research directions are summarized, with the goal of identifying the pieces of the Parkinson's puzzle that are going to have to be put together if we are to solve this mysterious disease.

Entities:  

Mesh:

Year:  2002        PMID: 12428715     DOI: 10.1016/s0161-813x(02)00098-0

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  20 in total

Review 1.  Redefining Parkinson's disease research using induced pluripotent stem cells.

Authors:  Jiali Pu; Houbo Jiang; Baorong Zhang; Jian Feng
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

Review 2.  Rifampicin and Parkinson's disease.

Authors:  Wei Bi; Lihong Zhu; Xiuna Jing; Yanran Liang; Enxiang Tao
Journal:  Neurol Sci       Date:  2012-07-21       Impact factor: 3.307

Review 3.  Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.

Authors:  Bin Liu
Journal:  AAPS J       Date:  2006-09-29       Impact factor: 4.009

Review 4.  A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.

Authors:  Shams Tabrez; Nasimudeen R Jabir; Shazi Shakil; Nigel H Greig; Qamre Alam; Adel M Abuzenadah; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

5.  Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.

Authors:  Minho Moon; Hyo Geun Kim; Lakkyong Hwang; Ji-Hyung Seo; Sehee Kim; Sunyoung Hwang; Soonyong Kim; Dahm Lee; Hyunju Chung; Myung Sook Oh; Kyung-Tae Lee; Seungjoon Park
Journal:  Neurotox Res       Date:  2009-03-17       Impact factor: 3.911

Review 6.  Genetics of parkin-linked disease.

Authors:  Andrew B West; Nigel T Maidment
Journal:  Hum Genet       Date:  2004-01-15       Impact factor: 4.132

7.  Chronic administration with rotenone does not enhance MPTP neurotoxicity in C57BL/6 mice.

Authors:  Eriko Aoki; Hironori Yokoyama; Hiroki Kimoto; Ryohei Yano; Hiroyuki Kato; Tsutomu Araki
Journal:  J Mol Neurosci       Date:  2009-07-31       Impact factor: 3.444

8.  Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease.

Authors:  Martin Darvas; Charles W Henschen; Richard D Palmiter
Journal:  Neurobiol Dis       Date:  2014-02-01       Impact factor: 5.996

Review 9.  The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery.

Authors:  Garima Dutta; Ping Zhang; Bin Liu
Journal:  Fundam Clin Pharmacol       Date:  2008-08-15       Impact factor: 2.748

10.  Flotillin-1 in the substantia nigra of the Parkinson brain and a predominant localization in catecholaminergic nerves in the rat brain.

Authors:  D M Jacobowitz; A T Kallarakal
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.